MENLO PARK, Calif., March 22, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the U.S. District Court for the District of Delaware denied a motion to dismiss filed on December 14, 2017 by Oxford Nanopore Technologies, Inc., a wholly-owned... Read more
Tue 20th March 2018 Funding will support new manufacturing facility, commercial expansion, and development of new innovative products. Oxford, UK. Oxford Nanopore Technologies Ltd, the company behind the only portable real-time DNA/RNA sequencer, MinION, has raised £100M ($140M) in new investment. Funds were raised from global investors including GIC (Singapore), CCB International (CCBI, China), Hostplus (Australia),... Read more
Thu 8th February 2018 In November 2016, PacBio filed a Complaint with the International Trade Commission (“ITC”) alleging that Oxford Nanopore infringed two of PacBio’s patents and seeking to prevent Oxford Nanopore from selling its product in the United States. Today, the ITC Commission has made a Final Determination affirming the Administrative Judge’s decision that... Read more
Thu 16th November 2017 Oxford Nanopore’s goal is to enable the analysis of any living thing, by anyone, anywhere. To get closer to this, we want to abolish the cold chain so that our reagents can be transported easily to any researcher and be used in any environment. With this in mind, we are now starting... Read more
Tue 17th October 2017 Oxford Nanopore is developing target enrichment processes for the nanopore sequencing platform, based on the CRISPR/Cas9 system. When coupled with real-time nanopore DNA analysis, these techniques are designed to help users target and resolve specific biological questions more quickly and efficiently than possible with whole genome sequencing. The first participants are... Read more
– Long-read, real-time DNA and RNA sequencing now available to researchers and clinical scientists through China’s preeminent and most comprehensive CLIA/CAP laboratory – WuXi NextCODE partners can now combine nanopore sequencing and the world’s leading informatics to solve genomics challenges with the potential to improve health SHANGHAI, CAMBRIDGE, Mass. and REYKJAVIK, Iceland, Oct. 17, 2017 /PRNewswire/ — WuXi NextCODE,... Read more
Thu 12th October 2017 中文版 October 2017: Oxford Nanopore sequencing technology is now available in China. The long-read, real-time, portable MinION sequencer is now being used by researchers across China, who are working on myriad DNA sequencing applications including: pathogen research, human genetics, plant genetics, animal genetics and metagenomics. Chinese researchers are also preparing to start cDNA and... Read more
Mon 26th June 2017 Oxford Nanopore has today launched two new sequencing kits, for direct or PCR cDNA analysis. This means that nanopore technology can now be used for a full range of RNA analyses, including: Direct RNA Sequencing Kit For the first time RNA can be sequenced directly, giving new insights including base modifications PCR... Read more